Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics.
Multiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success.
NDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers.
With 70+ thought-leaders converging at NDD Europe, this will be an unrivalled opportunity for you to gain the latest scientific insights, have your peers review your research and grow your collaborator network.
Detailed Event Name: NDD Europe 2019 – Neurodegenerative Drug Development Europe
Event Venue: Hilton Paris La Defense, 2 Place de la Défense, 92800, Puteaux, France
Event Date: 21st – 23rd May, 2019
Event website link: https://ter.li/iexnm7
Event Organizer Hanson Wade
Communication number (with country & area code): +44 (0)20 3141 8700
Email ID: firstname.lastname@example.org
Social Media Page Link: https://www.linkedin.com/groups/4807043/